Glooko, Author at Glooko

We’re thrilled to head to Barcelona, Spain, from March 11 to 14 for the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2026), the world’s premier forum where medicine meets innovation.

As clinicians, device manufacturers, and digital health companies gather to bridge the gap in diabetes care, Glooko is proud to be at the center of the conversation at booth 10 showcasing how our diabetes and glycemic management company is expanding the boundaries of digital health across the full continuum of care.

This year’s focus on AI-driven glucose prediction, smart insulin delivery, and next-generation artificial pancreas systems aligns with our mission to transform diabetes and glycemic care by simplifying workflows and providing care teams with the data-driven insights and technologies needed to improve patient outcomes.

Here’s what you’ll experience at our ATTD 2026 booth:

Glooko’s SSO and EHR Integrations: The Glooko diabetes management platform can be fully integrated into existing clinical workflows through its single sign-on (SSO) feature and EHR interoperability. Designed to streamline administrative workloads, these capabilities eliminate manual data entry and “password fatigue,” allowing healthcare providers to launch patient profiles, sync reports directly within their existing EHR systems, and prioritize patient care.
New Glooko Clinic Dashboard: Glooko’s new population health tool, available in select countries, helps clinics manage large diabetes populations by prioritizing patients based on clinical risk and analyzing engagement gaps. Our clinic dashboard simplifies complex data into an intuitive, high-level view of population trends and clinic metrics. By providing these “at-a-glance” insights, our tool empowers the entire care team to make faster, more informed decisions and refine their clinic strategy.
EndoTool Glucose Management System: As a pivotal step in advancing comprehensive inpatient and outpatient diabetes care, Glooko acquired Monarch Medical Technologies and its EndoTool Glucose Management System. The leading patient-specific inpatient insulin-dosing software, available only in the U.S., supports safer, more consistent glycemic management.

Meet with Team Glooko at ATTD 2026

Whether looking to reduce glycemic risk in the hospital or manage a large diabetes patient population in a clinic, find out why healthcare leaders choose Glooko for enterprise-wide, coordinated, data-driven care by visiting our booth or scheduling a demo.

EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.

It’s that time of year again — the HIMSS Global Health Conference and Exhibition in Las Vegas!

From March 9 to 12, Glooko, the leading diabetes and glycemic management company, will showcase its connected care solutions at booth 4103 of HIMSS26, the premier event for healthcare technology and digital health innovation.

With a focus on AI, cybersecurity, interoperability, and data-driven healthcare technology, we’ll demonstrate to C-suite leaders, clinicians, and IT specialists how the comprehensive Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, are transforming care delivery and meeting challenges across outpatient and inpatient settings.

What you’ll learn at our booth:

How we advance clinical workflow optimization: Manual workflows and “login fatigue” are bottlenecks care teams can’t afford. Both solutions, Glooko and EndoTool, integrate directly with leading electronic health records (EHRs), including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, to bring all diabetes, glycemic, and health data together, giving a complete view of a patient’s health in one place. Our seamless integrations eliminate the hassle of platform switching and security risks related to multiple disparate logins, passwords on sticky notes, and reused credentials, while reducing clinician burnout. Glooko is also available in the Epic Showroom for easier integration into the EHR.
The many ways we protect patient data across our solutions: For inpatient settings, EndoTool is available on HITRUST and SOC2-certified infrastructure, as well as on-premise solutions tailored for any IT environment. On the outpatient side, the Glooko platform boasts leading security certifications and has hundreds of security protocols in place to protect patient data and ensure compliance
Why we’re a leader in interoperability: The Glooko digital health solution unifies the fragmented diabetes ecosystem through seamless integration with more than 200 diabetes and health monitoring devices and apps. Whether patients use a BGM, smart insulin pen, or any other device in the diabetes ecosystem, Glooko syncs patient health data with its device agnostic platform. This provides care teams with critical information in one place, enabling more informed clinical decisions.
How we’re helping hospitals navigate insulin management with clarity and confidence: With new CMS public reporting requirements for glycemic measures and 1 in 3 hospitalized patients requiring glycemic management, EndoTool delivers measurable impact, including a 66% reduction in severe hypoglycemia, a 26% reduction in severe hyperglycemia, and reduced length of stay.

Experience how we’re transforming diabetes across the full continuum of care

Schedule a demo with one of our experts at the show to see how your team can benefit from our innovative, secure, and interoperable healthcare technology.

When you work in diabetes every day, you see the statistics, the market trends, and the clinical realities. When you look a little closer and listen to families navigating diagnosis or clinicians trying to personalize care in overextended health systems, you see something deeper. You see the people behind every data point. This perspective is why I am honored to serve as Chair for the 2026 Boston State of Diabetes event.

Serving as Chair is a responsibility that I care about deeply. Diabetes affects millions of people in this country, and each statistic represents a person, a family, and a community navigating something that touches every part of daily life. The American Diabetes Association (ADA) created the State of Diabetes initiative to elevate those experiences and to bring the diabetes community together in a focused and meaningful way.

This event has grown from eight cities in 2022 to more than thirty across the country today. Boston has always been one of the strongest markets for engagement and thought leadership, and the work that happens here often influences how the program evolves nationally. People come because they are looking for real information and real solutions. They want to hear from experts they can trust. They want to connect with others who understand what life with diabetes looks like and what is changing in the field.

At Glooko, our mission is to give people with diabetes and their care teams tools that make life easier and care more personalized. That work aligns closely with the goals of the ADA. The ADA continues to lead with science, education, advocacy, and support for communities that often need more resources and more transparency around the care they receive. The State of Diabetes creates a space for these priorities to come together. It also creates a place where innovators, clinicians, employers, payers, and community members can learn from one another.

What makes this initiative meaningful to me is the human side of the story. Behind every product, program, or policy are people who are trying to manage a demanding and constant condition. Many are newly diagnosed. Many are caring for a child or an aging parent. Many are clinicians working hard to avoid burnout and keep pace with changing technology and clinical guidance. The event gives us room to talk honestly about those experiences and to highlight the progress that is being made.

As Chair, I hope to help broaden that conversation by inviting new partners to participate, lifting up the important work of the ADA, and encouraging collaboration across the diabetes ecosystem. We have a full year of preparation ahead, and I look forward to sharing updates as we move toward the 2026 event in November.

My goal is simple. I want this initiative to reflect the reality of diabetes today and to shine a light on the ideas and partnerships that can move us forward. People living with diabetes deserve access to care that is reliable, informed, and compassionate. I believe this effort can play a role in creating that future.

EHR integrations provide a single, holistic view of patient data to streamline clinical workflows and enable more informed, data-driven decision-making at the point of care for healthcare providers.

Rady Children’s Hospital Diabetes Program Director Carla Demeterco-Berggren, MD, PhD, and Michigan Medicine Project Manager Chris Dallas share how they leverage EHR-integrated diabetes workflows in the Glooko diabetes management platform to reduce manual burden, improve visibility, and scale team-based care.

Moderated by Glooko Senior Clinical Transformation Director Trisha Martinez, BSN, MBA, RN, the session also covers why bringing diabetes data directly into the EHR is critical for improving efficiency, coordination, and care delivery across health systems.

Key Takeaways

Manual workflows eliminated: EHR integration replaces printing, scanning, copy/paste, and manual flowsheet entry with automated data delivery directly into the EHR.
Significant time efficiency gains: Both Rady Children’s and Michigan Medicine reported meaningful reductions in documentation and intake time after integrating Glooko into their EHR workflows.
Scalable, standardized care: One-click access, discrete flowsheet data, and remote visibility support telehealth expansion, improve coordination, and increase clinic capacity.

Watch the Webinar

Ready to bring diabetes patient data into the EHR?

Contact Team Glooko to discover how our seamless integrations with leading EHR systems, including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, can transform your practice. By embedding our diabetes management platform directly within existing clinical workflows, we provide secure access to critical data while eliminating the inefficiency of switching between platforms.

MKT-0522 01

The diabetes industry won’t just evolve in 2026. It will continue to undergo a fundamental shift in how care is defined, delivered, and experienced. What was once a landscape dominated by manual tracking and reactive treatments has transformed into a proactive, connected, data-driven ecosystem of diabetes devices, management platforms, manufacturers, digital therapeutics, consumables, educators, and drug therapies.

In 2026, the focus is no longer just about managing diabetes, but about mastering it through integrated data, connected devices and apps, and AI-enabled insights. Glooko’s core mission has always been to bridge the gap between people living with diabetes and healthcare providers through clear, actionable data. This year, we are strengthening that connection by offering innovative solutions like EndoTool, developed by Monarch Medical Technologies, a Glooko Company, and Glooko. Together, these technologies can bridge the continuum of care from inpatient glycemic management to outpatient diabetes management.

To better understand where the industry is going, we asked our experts for their insights and predictions for 2026.

Advancing Diabetes and Glycemic Management in 2026

“The diabetes landscape is set for a massive transformation in 2026. With the launch of the CMS ACCESS Model, we are shifting from simply tracking data to rewarding positive health outcomes during hospital stays. However, as a wave of new CGMs, AI-enabled health software and wearables, and smart pens hits the market, these technologies can quickly overwhelm outpatient care teams. Trusted digital health solutions that bridge these settings, unifying disparate devices into one clear, actionable clinical picture using data, will be key.

This move toward data liquidity means vital information is no longer trapped in a single device or clinical encounter. By integrating inpatient systems with outpatient platforms, care can be more proactive and continuous, especially as new federal quality measures for glycemic safety take full effect this year. We aren’t just looking at numbers anymore; we need to use intelligent, AI-powered insights to make the daily burden of diabetes feel lighter. We’re moving beyond ‘tech for tech’s sake’ and toward a simpler, more connected reality that puts the person before the data.”

– Mike Alvarez, CEO, Glooko

The Rise of New Digital Health Standards and Connected Care

“In 2026, the strategic focus for health systems will shift from fragmented point solutions to a unified continuum of care. As hospitals face tightening margins and new outcome-based payment models like CMS ACCESS, they’ll seek integrated platforms that standardize management for chronic conditions like diabetes across both inpatient and outpatient settings. By consolidating disparate tools into a single, EHR-integrated ecosystem, systems can reduce the cost of maintaining multiple interfaces.

Remote patient monitoring will also see new life in 2026. New programs like the federal Rural Health Transformation Program are bridging the “digital divide” and refocusing on the benefits of connected, digital-forward care. This $50 billion funding allows underserved, rural clinics to adopt advanced AI and remote monitoring tools that were previously limited to urban centers, enabling evidence-based chronic condition management closer to home. By leveraging grants to modernize interoperability and cybersecurity, rural healthcare providers ensure that high-quality, connected diabetes care is no longer determined by a patient’s zip code, but is instead the universal standard.”

– Rich Glenn, President, Connected Care, Glooko

Evolving from Siloed Data Collection to Integrations and Precision Engagement

“This year, we will keep expanding our current support of episodic care to include continuous care, evolving beyond our expertise in data collection to the design of digital ecosystems that bridge the gap between people with diabetes, their device data, and healthcare providers. This shift will replace fragmented data silos with a unified infrastructure where information from diabetes devices and health monitoring apps flow seamlessly into clinicians’ primary workflows via EHR integrations. We must ensure that continuous data isn’t an overwhelming burden, but an enabling and actionable asset. This collaborative framework alleviates burnout by giving the entire care team an on-demand ‘single source of truth,’ allowing care teams to intervene proactively and spend less time navigating software and more time practicing at the tops of their licenses.

Given recent FDA guidance on wellness wearables and clinical decision support software, we may now be entering a new era of precision engagement fueled by AI. With the latest generations of CGM devices and automated insulin delivery (AID) systems, the field has already moved beyond just seeing data to predicting outcomes and using AI to forecast hypoglycemic events with immediate, context-rich alerts to the person with diabetes. This automation allows patients to manage their care more independently than ever before. However, people with diabetes still benefit from expert teams that can co-pilot their care. There will always be a vital need for care teams to step in when clinical complexity arises or the individual is not achieving their diabetes management goals.”

– Mark Clements, MD, PhD, Chief Medical and Strategy Officer, Glooko

Making Glycemic Safety a Mandatory Protocol

“In 2026, inpatient glycemic safety will transition from a clinical preference to a mandatory system requirement. With CMS now linking reimbursement and quality ratings to the reporting of severe glycemic events, hospitals can no longer rely on the manual vigilance of individual clinicians to manage insulin therapy. Success now requires moving away from fragmented “sliding scale” protocols and toward purpose-built platforms like EndoTool that ensure consistent, evidence-based dosing and the ability to track outcomes in real time. By treating glycemic management as core safety infrastructure, hospitals and health systems can reduce costly variability, meet new regulatory demands, and allow clinicians to focus on patient care rather than manual calculations.”

– Paul Chidester, MD, Medical Director, Glooko

View Dr. Chidester’s full 2026 outlook on glycemic safety

Solving Specialist Shortages and Clinician Burnout Through Integrated AI and Enhanced Patient Literacy

“Clinician burnout will remain a top priority in 2026, driven in part by the mental exhaustion of managing disjointed tools outside the EHR. This year marks a turning point: embedding integrated data and interoperability within existing workflows will automate administrative tasks, streamline documentation, and provide unified patient views for better clinical decisions. The result will likely be improved provider capacity, proactive care delivery, and sustainable models that optimize both clinical and operational outcomes.

As the endocrinologist shortage intensifies, primary care teams will increasingly leverage specialized healthcare AI tools, including ChatGPT for Healthcare, to reduce administrative burden and enable top-of-scope care delivery, effectively increasing capacity without adding staff.

We will continue to be immersed in the era of the AI-empowered patient. Patients already use tools like ChatGPT Health to synthesize their data, including glucose trends and lab results, before appointments. This increasing health literacy will continue to transform basic data reviews into high-value, collaborative discussions where both clinicians and patients leverage AI for more informed decision-making.”

– Trisha Martinez, BSN, MBA, RN, Senior Director, Clinical Transformation, Glooko

Securing the Digital Health Ecosystem to Thwart AI-Driven Cyberattacks

“In 2026, healthcare data privacy and cybersecurity will undergo a fundamental shift as cyber threats transition to AI-driven, autonomous models. Healthcare organizations must pivot toward ‘agentic resilience,’ a proactive approach leveraging agentic AI, autonomous systems capable of making decisions and executing tasks. These agents can address the vulnerabilities inherent in connected medical ecosystems, such as the possible cyberattack risks present in clinical workflows and medical devices, including connected insulin pumps and CGMs.

To mitigate security risks in 2026, healthcare organizations should also transition toward a robust security framework that replaces traditional passwords with identity-based access control and advanced authentication methods, such as biometric passkeys and MFA. By implementing universal verification, every access request can be rigorously validated regardless of its source, ensuring the integrity of clinical workflows and protecting sensitive health data from unauthorized entry.”

– Ben Chang, Vice President, Security and IT Operations, Glooko

Entering a Highly-Competitive, Integration-First Diabetes Device Ecosystem

“We’re entering the year in a global diabetes landscape that has matured into a competitive, integration-first ecosystem that demands collaboration. With the global diabetes device market projected to exceed $37.9 billion, we are seeing an influx of regional manufacturers offering new device alternatives, giving healthcare providers and people with diabetes a wider array of care choices. This diversification is further accelerated by the mainstream adoption of tubeless patch pumps, CGMs, and non-invasive wearable technologies tailored for the Type 2 diabetes and wellness segments.

From a partnership perspective, these trends reinforce a vital market truth that hardware is no longer a standalone solution. As the number of devices expands, the ultimate competitive advantage belongs to those who prioritize interoperability, integrating effortlessly into the patient’s life and the clinician’s EHR system.”

– Dave Conn, Executive Vice President, Global Alliances, Glooko

Furthering Connected Diabetes Care in Europe

“We’ll continue to move away from disconnected diabetes devices and toward integrated digital ecosystems. As connected care becomes the standard for delivering value, diabetes management will increasingly rely on a coordinated combination of medication, smart hardware, and artificial intelligence, all operating under the supervision of healthcare professionals through structured remote monitoring.

For remote monitoring to be effectively adopted, it must be embedded within national and regulatory frameworks defined by local health authorities. Strict alignment with evolving EU regulations on AI and health data will also remain a central priority.

In terms of devices, the evolution of algorithm-driven AID systems into sophisticated ‘digital companions’ will be the catalyst for a broader diabetes management transformation. By combining predictive AI with remote monitoring, healthcare providers can anticipate patient needs and manage populations remotely, offering a scalable solution to Europe’s workforce challenges by effectively shifting care from hospital settings into the home.”

– Alex Evans, Vice President, Connected Care, EMEA, Glooko

Smarter Technology to Empower People Living with Diabetes

“Over the past few years, managing my diabetes finally felt less like a full-time job and more like a background app running on my phone. We’ve moved away from the constant stress of finger sticks and manual math thanks to the latest AID systems and high-tech sensors that talk to each other better than ever before. These smart systems do the heavy lifting for many, catching highs and lows before they even happen, which takes a huge weight off the shoulders of people with diabetes. Even for those of us who don’t use a pump, connected smart pens can now automatically log every dose, so there’s a lot less guessing and worrying. In 2026, I think we’ll see even more technology that helps to further reduce burnout, keep costs more manageable, and help people stay in range, while thinking about diabetes a little less.”

– Hadley Horton, Senior Partner Manager, Glooko

Ready to prepare your hospital, health system, or clinic for the rest of 2026?

Contact our team for a demo of our outpatient Glooko diabetes management platform and inpatient EndoTool Glucose Management System.

In clinics and hospitals across Europe, healthcare providers are facing the common challenge of administrative overload.

We’ve heard that care teams at clinics and hospitals in the United Kingdom, Germany, Austria, Switzerland, Norway, Sweden, and Denmark need a more streamlined way to securely access our diabetes management platform and a more seamless integration of health data of patients into their daily clinical workflows.

Designed to streamline diabetes care workflows, our latest enhancements, including SSO and EHR integration, aim to provide secure access, automate workflows, and save care teams time.

Simplified and Secure Access with Single Sign-On

In fast-paced clinical environments, every second counts. Between patient consultations and appointment follow-ups, the last thing healthcare professionals need is another set of login credentials to memorize.

To increase efficiency, the Glooko diabetes management platform, compliant with GDPR and the NHS Data Security & Protection Toolkit, features single sign-on (SSO) functionality. Instead of using a separate username and password, clinical teams can access Glooko using their existing hospital credentials.

Why are clinics switching to SSO in Europe?

Seamless Access: The experience is intuitive. Users simply enter their professional email address and Glooko automatically authenticates them against their healthcare organization’s existing identity management platform.
Enhanced Security: By leveraging a hospital’s existing security protocols, SSO reduces the risks associated with weak or recycled passwords, keeping sensitive patient health data secure.
Maximum Efficiency: No more time wasted on login screens, forgotten password requests, and locked accounts.
Fast Implementation: The setup process is straightforward and we can typically have healthcare organizations connected to our platform, backed by leading security certifications, in less than two days.

End Manual Data Entry and Stop Toggling with EHR Interoperability

The administrative burden of maintaining patient records is one of the primary causes of clinician burnout. Too often, healthcare providers are forced to act as data entry clerks, manually transcribing glucose logs, insulin data, and reports into the EHR (electronic health record), instead of analyzing that data to improve care.

To eliminate this manual work and limit switching between screens, Glooko offers integrations designed to automate the flow of health information, making the EHR and our diabetes management platform work as a unified system.

By bridging the gap between systems, Glooko helps reduce manual burden and combat clinician burnout:

Launch from EHR: Open a patient’s full Glooko profile directly from the EHR interface. No extra tabs, no re-searching for names.
Sync to EHR: Automatically upload diabetes data and detailed reports from Glooko straight into the EHR to keep more comprehensive patient records.

By connecting these two systems, care teams can spend less time managing software and more time with their patients.

Ready to simplify your clinic’s digital environment?

Contact Team Glooko to find out the next steps needed to activate SSO and integrate our innovative diabetes management solution into the EHR.

For technical details, visit our API and EHR Integration Portal.

We’re excited to share the latest updates included in Glooko Web 25.4 and Glooko Mobile 6.14, which are designed to help healthcare providers and care teams move faster with easier-to-understand risk insights, while also making it easier for people living with diabetes to connect devices and apps and remotely share data with their care teams.

Enhancements to the Glooko Clinic Dashboard

The Glooko clinic dashboard, designed to improve diabetes population health management and available in select countries, now features enhanced usability and accuracy improvements, making risk insights clearer for faster action across clinics, hospitals, and health systems.

Other enhancements to our population health tool include:

Clearer risk visibility: An updated Time in Range layout makes low and very low glucose risk easier to identify at a glance.
Smarter patient ranking: Patients with diabetes are prioritized by risk category, then by severity of the triggering metric.
More precise metrics: Risk indicators are displayed with greater precision for clearer comparison and trend tracking.

More Efficient Patient Review in the Glooko Web App

The patient list in the Glooko Web App for healthcare providers has been enhanced to support faster, more efficient workflows and smoother navigation.

Care teams can now see more patient data at once with a wider default view that reduces horizontal scrolling, sort patients better with improved cues that make patient order easier to understand, and see key context through a revised header that stays visible as they scroll through the list.

Streamlined Clinical Workflows with Full Glooko Access in Epic

Healthcare providers using Patient Portal for Professionals can now access the full Glooko Web App directly within the Epic EHR system using SSO via SMaRT on FHIR, reducing platform switching and streamlining daily workflows.

Some of the benefits of this helpful enhancement include launching our diabetes management platform without leaving the EHR or logging in again, the use of core features including the clinic dashboard, patient list, and device assignment within Epic, faster review and action using key patient diabetes data, and reduced clinician burnout from not context switching.

If your clinic is interested in this feature, please email [email protected].

Simplified Device and App Management for People with Diabetes

Managing diabetes and health monitoring devices and apps is now quicker and intuitive in the Glooko Mobile App.

Our newly enhanced search and smarter filtering, better device categorization, and refreshed visuals, including logos, make it easier for people with diabetes to find and connect their devices and apps with fewer clicks. The update also features shortcuts to speed up Glooko’s seamless integration with more than 200 compatible diabetes and health monitoring devices and apps. Once connected, patient data can be securely shared remotely with care teams who can make more informed treatment decisions.

More Information on the Latest Glooko Release

To learn more about these updates, check out the full release notes on our Support Center or reach out to your dedicated Glooko Customer Success Manager.

Team Glooko will be at the American Diabetes Association’s 2026 Clinical Update Conference from February 6 to 8 in Houston, Texas, showcasing how our inpatient and outpatient solutions are helping hospitals and health systems address the growing challenge of glycemic safety and diabetes management and advancing team-based diabetes care.

Through our recent acquisition of Monarch Medical Technologies, we are now uniquely positioned to reduce glycemic risk, improve patient safety, and support overburdened clinical teams through coordinated expertise across the full continuum of care.

Here’s what you can learn about the Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, at booth 17.

How to move from data overload to workflows that actually work: Disconnected systems, manual PDFs, and multiple logins slow care teams down and increase risk. Our EHR-integrated diabetes workflows in Glooko and EndoTool reduce manual burden, improve visibility, and enable consistent care across clinical, education, and operational teams.
Methods for preparing for mandatory CMS glycemic reporting: Hospitals are preparing for mandatory severe hypo- and hyperglycemia reporting from the Centers for Medicare & Medicaid Services. EndoTool, our patient-specific insulin dosing system, helps hospitals achieve unmatched clinical outcomes, reduce variability, and support CMS readiness with confidence.
Ways we align with the 2026 ADA Standards of Care: We’re helping clinicians and health systems turn the American Diabetes Association’s 2026 Standards of Care into reality. By streamlining data, enhancing team-based diabetes care, and delivering actionable insights, we’re bridging the gap between clinical guidelines and measurable outcomes to improve life for patients and their healthcare providers.
Tools for improving diabetes population health management: Designed for busy diabetes care team members, Glooko’s user-friendly clinic dashboard, now available in select countries, provides quick insights into patient trends and key clinic metrics to help clinics, hospitals, and health systems achieve better enterprise-wide diabetes management.

Leverage the power of team-based diabetes care

Schedule a demo with one of our experts at the ADA Clinical Update to see how your team can benefit from our innovative digital health platforms.

Through our ongoing commitment to enhancing diabetes care and simplifying diabetes management, we launched a redesigned food tracking experience in the Glooko Mobile App, making logging faster, more flexible, and even more insightful.

This powerful upgrade, featured in the Glooko Web App 25.3 and Mobile 6.13 release, is designed with the core purpose of making it easier for people with diabetes to log meals and for clinicians, endocrinologists, and the entire care team to streamline reviewing nutrition data alongside glucose trends, insulin doses, and exercise.

The new interface transforms the meal logging process, ensuring people with Type 1 diabetes, Type 2 diabetes, gestational diabetes, and prediabetes are more engaged with their nutrition tracking than ever before. For clinicians, the tool delivers the rich, contextual data needed for more impactful appointments and timely, data-backed interventions.

Ways for Easier and More Flexible Food Logging

The goal of the redesign was simple: make tracking food as quick and intuitive as possible for Glooko Mobile App users with diabetes. The new mobile experience allows users to:

Log Meals by Type: Start by simply selecting a meal type (breakfast, lunch, dinner, or snack).
Multiple Input Methods: Add food items instantly through a variety of convenient methods:
- Manual search of our expansive database of food items (Select languages only)
- Barcode scanning (U.S. only)
- Voice input (Select languages only)
- Quick add from our food database or through custom entry
Customize and Save Favorites: App users can now create custom food entries and easily mark meals or food items as favorites with a single tap of a heart for lightning-fast logging next time.
Review Before Saving: The ability to edit existing items for time, data, and serving size, or review the full meal with detailed nutritional summaries ensures accuracy before the data is saved.
View the Summary: A nutritional summary now appears after each logged meal to help users better understand their daily intake.

Providing Smarter Nutrition Insights and Visualizations

The new design goes beyond logging to provide users with a clearer picture of their diet composition:

Track Macro Distribution: The Glooko Mobile App now tracks the distribution of carbs, fat, and protein as a percentage of total calories per day. This vital feature helps users quickly assess if macro intake aligns with dietary goals and how it may be influencing glucose patterns.
Data-Packed Charts and Graphs: The simplified logging process means more consistent data, which is viewable in the Daily Log and a new Food Graph below the Carbs section of Charts and Graphs, allowing users to better understand diet-related glucose fluctuations and discuss potential changes with their care teams.
Enhanced Meal Visualization: Users and care teams can now view added meals directly in the History List of the Glooko web app, with each entry displaying the exact meal type, nutritional information, and details of the included food. This enhanced visualization provides a better understanding of how nutrition works together with insulin doses, exercise, medications, and weight. Previous views of carbs are still available in the Overview Graph, Daily Graph, Weekview, and Calendar.

A Comprehensive Approach to Diabetes Management

This revamped food tracking experience is more than just an update — it’s a powerful tool designed to foster better patient engagement and deliver insightful data people with diabetes and their healthcare providers need to manage diabetes more effectively.

With nutrition, exercise, medication, lifestyle management, and other health data, we’re creating a better way to manage diabetes. To get started, download the Glooko Mobile App on the App Store and the Google Play Store today.

*Not all product features are available in all countries.

We are thrilled to be an exhibitor at the ADCES Diabetes Technology Conference (DTC25) in Chicago on December 12 and 13. This unique event focuses on how cutting-edge technology, like Glooko, can empower diabetes care teams and improve outcomes for people with diabetes.

During the show, we’ll share at table #18 how Glooko delivers essential clinical advantages. Attendees will see firsthand how our diabetes management software, compatible with more than 200 diabetes and health monitoring devices and apps, enables care teams to effortlessly analyze patient data, streamline care coordination, and tailor interventions that can lead to improved health outcomes.

Here’s what we’ll showcase at DTC25:

New Glooko Clinic Dashboard: Designed specifically for busy healthcare providers, the new dashboard in Glooko offers an organized, at-a-glance view of patient trends and crucial clinic metrics. This powerful tool enables care teams to make more informed treatment decisions and build a stronger clinic strategy.
Seamless EHR Integrations: Glooko streamlines clinical workflows by integrating securely with leading EHR systems. This functionality eliminates the need for healthcare providers to switch platforms, giving care teams a complete, centralized view of all diabetes and related health data within a single, familiar interface, allowing them to work more efficiently.
EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: Recently acquired by Glooko, EndoTool is the leading patient-specific inpatient insulin-dosing software trusted by 8 of the top 10 U.S. health systems to support safer, more consistent glycemic management at the bedside.

Elevate your practice with our innovative diabetes management platform

Ready to see how Glooko can elevate your clinic? Schedule a meeting with one of our experts at DTC25.